Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C

Hepatitis C Virus (HCV) infects 2% of the world’s population and is the leading cause of liver disease and liver transplantation. It poses a serious and growing worldwide public health problem that will only be partially addressed with the introduction of new antiviral therapies. However, these trea...

Full description

Bibliographic Details
Main Authors: Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Joseph Torresi, Eric J. Gowans, Branka Grubor-Bauk
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Microbiology
Subjects:
viral hepatitis
hepatitis C virus
preventative vaccination
virus-like particles
immune response
liver disease
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2017.02413/full

Internet

http://journal.frontiersin.org/article/10.3389/fmicb.2017.02413/full

Similar Items